Submission Details
| 510(k) Number | K152614 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 14, 2015 |
| Decision Date | March 07, 2016 |
| Days to Decision | 175 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K152614 is an FDA 510(k) clearance for the Xpert Carba-R, a System, Nucleic Acid Amplification Test, Dna, Carbapenem Non-susceptible Gram Negative Organism, Colony (Class II — Special Controls, product code PMY), submitted by Cepheid (Sunnyvale, US). The FDA issued a Cleared decision on March 7, 2016, 175 days after receiving the submission on September 14, 2015. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.1640.
| 510(k) Number | K152614 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 14, 2015 |
| Decision Date | March 07, 2016 |
| Days to Decision | 175 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | PMY — System, Nucleic Acid Amplification Test, Dna, Carbapenem Non-susceptible Gram Negative Organism, Colony |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.1640 |
| Definition | To Detect The Presence Of Genetic Markers Of Antimicrobial Resistance By Testing Isolated Bacterial Colonies Using Nucleic Acid Amplification Technology. |